CCL2 and Sepsis: In contrast, antibody neutralization of MCP-1 in the CLP context had a beneficial effect on survival [14], and the administration of an MCP-1-synthesis inhibitor, bindarit, was also reported to be beneficial in different murine models of sepsis [29].